December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

29.05 +0.80 (+2.81%)
Streaming Delayed Price Updated: 2:37 PM EDT, Jul 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enovis Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
New full-range solution adds bone-sparing baseplate, peripheral fixation, and glenosphere options to proven reverse shoulder prosthesis (RSP®) glenoid baseplate while maintaining hallmark simplicity... 
From Enovis Corporation
Via GlobeNewswire
News headline image
Critical Insights From Enovis Analyst Ratings: What You Need To Know ↗
 
Via Benzinga
News headline image
A Closer Look at 6 Analyst Recommendations For Enovis ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks That Could Blast Off In June ↗
 
Via Benzinga
News headline image
5 Medical Info Systems Stocks To Buy For Stable Returns ↗
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024. 
Via Talk Markets
News headline image
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
News headline image
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗
 
Via Benzinga
News headline image
ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024 ↗
ENOV stock results show that Enovis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Earnings Outlook For Enovis ↗
 
Via Benzinga
News headline image
5 Analysts Have This To Say About Enovis ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 6 Takes On Enovis ↗
 
Via Benzinga
News headline image
Analyst Ratings for Enovis ↗
 
Via Benzinga
News headline image
Enovis Announces First Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
News headline image
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact ↗
Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent... 
Via Benzinga
Topics Earnings
News headline image
Enovis Announces Fourth Quarter and Full Year 2023 Results
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and STAR® Ankle will be featured as part of the company’s growing evidence-based, innovative portfolio. 
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
The newest innovation in unloader braces is comfortable, easy to use and effective. 
From Enovis Corporation
Via GlobeNewswire
News headline image
This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis ↗
William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth,... 
Via Benzinga
News headline image
Enovis Completes Acquisition of LimaCorporate S.p.A
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
News headline image
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch ↗
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising  
Via Benzinga
News headline image
Enovis Announces Business Segment Leadership Transition Plan
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference
From Enovis Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.